Among these, CDH13, TIAM1 and PCDH17 were up- and FLRT1 and OPCML down-regulated, thus indicating that the invasion capacity of glioma cells can be altered by cisplatin treatment. This evidence concerns the gene OPCML and central nervous system cancer.